Skip to content

Comparing levonorgestrel intrauterine system with vaginal niche repair in women with postmenstrual spotting related to a large niche in the uterine cesarean scar: protocol of a randomised controlled trial

Comparing levonorgestrel intrauterine system with vaginal niche repair in women with postmenstrual spotting related to a large niche in the uterine cesarean scar: protocol of a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099816
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The rapid increase in the rate of caesarean section (CS) worldwide in recent decades has aroused great concern about the niche of caesarean section incision and its potential long-term complications. A niche is defined as an indentation in the myometrium at the site of the previous uterine cesarean scar with a depth of at least two mm. Among women with a history of CS, a niche is present in at lea

Interventions

LNG-IUS group:LNG-IUS placement
Vaginal niche repair group:undergo vaginal niche repair surgery

Sponsors

The international peace maternity and child health hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Women (18–45 years); 2. Women having postmenstrual spotting after CS, defined as two or more days of intermenstrual spotting or as two or more days of brownish discharge immediately after the menstrual period in case the total period of the menstrual bleeding exceeds 7 days, if the period is shorter than 7 days the brownish discharge is considered to be normal; 3. Presence of a large symptomatic niche after caesarean section, defined as a niche with a depth of >50% of the total myometrial thickness at the anterior wall and with a maximum sagittal area >= 50 mm^2 using MRI; 4. Without a desire to conceive within 2 years; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Women who has a positive urine pregnancy test. If the urine test cannot be confirmed as negative, a serum pregnancy test will be required; 2. Presence of an intrauterine device; 3. Women with a contraindication for a vaginal niche repair or LNG-IUS 52mg or not willing to receive this type of treatment. 4. Women with a contraindication to epidural or general anesthesia. 5. Coagulation disorders that lead to higher risk on bleeding, a (suspected) malignancy, submucosal fibroids, polyps, atypical endometrial cells, cervical dysplasia, cervical or pelvic infection, hydrosalpinx that communicates with the uterus; known endocrine disorders that interfere with the menstrual cycle; 6. Irregular menstrual cycle (>35 days or intercycle variation of 2 weeks or more) before the CS or currently an irregular (natural) cycle. 7. Refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
the total bleeding days of postmenstrual spotting symptoms associated with large niche;

Countries

China

Contacts

Public ContactJian Zhang

The international peace maternity and child health hospital

ipmch@foxmail.com+86 21 6407 0434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026